Why the study?
CMR enables one-step evaluation of myocardial function and pathology after STEMI, but the predictive value of combining fast MVO identification from CE-SSFP with myocardial strain for MACE remained to be evaluated.
Does fast MVO identification from CE-SSFP combined with myocardial strain predict MACE in patients with STEMI after primary PCI?
Population
237 STEMI patients who underwent pPCI and completed CMR within 1 week
Comparison
Fast MVO identification from CE-SSFP combined with myocardial strain
Design
Cohort study
Follow-up
13 months [IQR: 11–24]
Key result
Microvascular occlusion identified from contrast-enhanced cine was independently associated with major adverse cardiovascular events (HR 3.10) in patients with STEMI after primary PCI.
Authors
Loading...
MVO on contrast cine may aid post-STEMI risk stratification; leaves open prospective validation of combined strain assessment before clinical adoption.
Cohort (n=237)
No
Does fast MVO identification from CE-SSFP combined with myocardial strain predict MACE in patients with STEMI after primary PCI?
Effect estimate: HR 3.10 (95% CI 1.14-8.99)
p-value: p=0.028
Fast MVO identification from contrast-enhanced cine combined with global longitudinal strain provides a reliable and quick prognostic tool for predicting MACE in STEMI patients after primary PCI.
Zhang et al. (2022) conducted a cohort in ST-elevation myocardial infarction (STEMI) (n=237). Microvascular occlusion (MVO) identification from contrast-enhanced cine (CE-SSFP) was evaluated on Major cardiovascular adverse events (MACE) (HR 3.10, 95% CI 1.14-8.99, p=0.028). Microvascular occlusion identified from contrast-enhanced cine was independently associated with major adverse cardiovascular events (HR 3.10) in patients with STEMI after primary PCI.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: